Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: BIOLOGICAL: Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Breast Cancer|PROCEDURE: cryotherapy
Sponsor: Fuda Cancer Hospital, Guangzhou
Collaborators: Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.